Loading
No insider purchase over the last 90 days. The latest was filed 16 Feb 2016.
Xenoport Inc is a listed company. Filings by its managers are published through SEC (Form 4). Xenoport Inc has had no insider filing for more than a year; the last one goes back to 16 February 2016.
Elsewhere in the same market, our signals recently picked up insider purchases at Relmada Therapeutics, Inc. and Uber Technologies, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
FY ended December 2015 · cache
21 of 21 declarations
Xenport Inc is a NASDAQ-listed company focused on developing treatments for chronic diseases. It emphasizes innovation in the pharmaceutical sector.